Not every hearing loss claim is about noise. A long list of medications can damage the inner ear - a property called ototoxicity - and when the medication was prescribed to treat a service-connected condition, the resulting hearing loss can be service connected in its own right.
This is a secondary claim, and it follows the rules in 38 CFR 3.310.
The medications involved
The ototoxic list is long, and several of its members are common in veteran care: high-dose loop diuretics used in heart and kidney conditions, certain chemotherapy agents, high-dose or prolonged salicylate and NSAID use, some antibiotics given intravenously, and long-term high-dose aspirin therapy. The damage can be temporary or permanent, and it can hit hearing, balance, or both.
The practical point is the chain: service-connected condition, prescribed treatment, documented hearing change. Each link is a record somewhere in the file.
How the secondary claim works
Under 38 CFR 3.310, a disability caused or aggravated by an already service-connected disability is service connected in its own right. For ototoxic hearing loss, the opinion has to connect three things: the service-connected primary condition, the medication actually prescribed for it, and the hearing loss, with reasoning that the medication was a contributing cause.
The claim is strongest when the timeline is clean - normal or better hearing before the medication, documented change during or after it, and no competing explanation that fits better. Our secondary service connection guide explains the standard the VA applies.
What the evidence has to show
Three records carry this claim. The prescription record showing the medication and dose. The audiological record showing the hearing change - which is why periodic audiograms matter if you take a known ototoxic drug long-term. And the medical opinion tying it together with mechanism, not assertion.
When the medication came from VA care, the prescription history is easy to obtain. When it came from private care, pharmacy records fill the gap. Our evidence guide covers the file as a whole.
Where an independent medical opinion fits
The VA often concedes the hearing loss is real and the medication happened, then denies the link between them. That is the medical question, and it is what a reasoned opinion answers: it reviews the records, explains the ototoxic mechanism and dose relationship, addresses the age and noise alternatives, and reaches a conclusion. Our nexus letter guide explains what that contains, and a medical records review is where veterans start when they are not sure the file supports one.
Monitoring during treatment with ototoxic drugs
Providers who prescribe known ototoxic medications, particularly certain chemotherapy agents and long courses of loop diuretics, sometimes order baseline and follow-up audiograms specifically to monitor for hearing changes during treatment. When this monitoring exists, it produces exactly the kind of before-and-after audiometric comparison that supports a secondary service connection claim.
If you are currently taking, or have previously taken, a medication known for ototoxicity to treat a service-connected condition, asking your prescribing provider whether periodic hearing monitoring is appropriate can create useful documentation well before any claim is filed.
Documenting the dose and duration relationship
Ototoxicity is often dose- and duration-dependent, meaning higher doses or longer courses of a medication carry greater risk of permanent hearing damage. Pharmacy records showing the specific drug, dosage, and length of treatment help a medical opinion establish whether the exposure was consistent with a level known to cause hearing damage.
This is different from noise-induced claims, where the exposure history is often described qualitatively. For ototoxic claims, the more precise the dosing and timeline evidence, the stronger the medical reasoning connecting the medication to the hearing change can be.
Balance and vestibular symptoms
Some ototoxic medications damage the vestibular system along with the cochlea, producing dizziness, unsteadiness, or balance problems in addition to hearing loss. When this occurs, it may be worth discussing with a provider whether a separate claim for a vestibular disorder is appropriate, since balance disorders are evaluated under different diagnostic codes than hearing loss itself.
Documenting both the auditory and vestibular symptoms in medical records, rather than only the hearing complaints, gives a fuller picture if both types of ototoxic damage occurred from the same medication exposure.
Frequently asked questions
Is hearing loss from chemotherapy covered by VA disability?
It can be, through secondary service connection under 38 CFR 3.310, when the chemotherapy was prescribed to treat a service-connected condition such as a service-connected cancer. The claim requires documentation of the specific agent, the dose, and a medical opinion linking the ototoxic mechanism to the hearing change.
Can hearing loss from a non-service-connected condition's treatment be claimed?
Generally no, because 38 CFR 3.310 requires the medication to have been prescribed for an already service-connected disability. If the underlying condition being treated is not itself service connected, the secondary path for the resulting hearing loss is not available.
How is ototoxic hearing loss different from noise-induced hearing loss on an audiogram?
Ototoxic damage often produces a different pattern than noise trauma, sometimes affecting higher frequencies first or progressing more suddenly during treatment rather than gradually over years. An audiologist or physician can describe whether the audiometric pattern is consistent with a medication-related cause, which strengthens the medical opinion.